The 15th China Pharmaceutical Entrepreneurs, Scientists, and Investors Conference, hosted by the China Pharmaceutical Enterprise Management Association, the China Pharmaceutical Biotechnology Association, the Hangzhou Investment Promotion Bureau, and the Linping District Bureau of Commerce, was held in Hangzhou from November 1 to 3, 2023. It was hosted by the E Pharmaceutical Managers and the China Healthcare Industry Investment 50 Forum. Zhang Min, Chairman of Mengyang Pharmaceutical, was invited to participate in the 2023 First Chinese Medicine CEO Forum and discussed and shared the challenges faced by the current Chinese medicine industry in terms of policies, capital, modernization, research and development innovation, and high-quality development. At the award ceremony hosted by E Pharmaceutical Manager, Mengyang Pharmaceutical was honored with the "2023 Best Practice Case of Traditional Chinese Medicine Inheritance and Innovation 50".

The award of "50 Best Practice Cases for Inheritance and Innovation of Traditional Chinese Medicine in 2023" is a recognition and motivation from the pharmaceutical industry for Mengyang Pharmaceutical, which is committed to exploring the treasure of traditional Chinese medicine in China and developing classic formulas and effective ingredients from natural medicines into new drugs. Mengyang Pharmaceutical will adhere to the principle of serving the country through industry and continuous innovation, with the mission of "improving the quality of life of cancer patients", Dedicated to becoming a leader in the field of tumor treatment-related diseases. Mengyang Pharmaceutical will leverage its corporate advantages, continuously explore and research, closely collaborate, and strive to develop classic formulas of renowned traditional Chinese medicine and effective ingredients derived from natural medicines into new drugs. It will integrate traditional Chinese medicine and Western medicine for innovation, inherit the wisdom of traditional Chinese medicine, extract the essence of Western medicine, and contribute to the contemporary cancer prevention and treatment industry.